MEI Pharma, Inc. (MEIP)


Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading MEI Pharma, Inc. chart...

About the Company

Chang Yi Wang (traditional Chinese: 王長怡; simplified Chinese: 王长怡; pinyin: Wángzhǎngyí; IPA: [tʃɒ̌ŋ jí wɒ́ŋ]) is the founder of United Biomedical, Inc. (UBI), headquartered in Hauppauge, New York, and its group of companies in Asia (including United Biomedical Asia).

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

127

Exchange

Nasdaq

$72M

Total Revenue

127

Employees

$22M

Market Capitalization

1.25

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $MEIP News

MEI Pharma shelves plans for a second return of capital

14d ago, source: Seeking Alpha on MSN

MEI Pharma (NASDAQ:MEIP) announced Thursday that its board of directors unanimously agreed not to proceed with plans to offer ...

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum

15d ago, source: The Bakersfield Californian

MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care cancer therapies, today announced ...

HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers

1d ago, source:

HOOKIPA’s HB-700 program is designed to treat KRAS-mutated lung, colorectal, pancreatic and other cancers by targeting the five most prevalent KRAS mutations in these disease indications: G12D, G12V, ...

PTC Therapeutics: Q1 Earnings Snapshot

13h ago, source:

SOUTH PLAINFIELD, N.J. (AP) — SOUTH PLAINFIELD, N.J. (AP) — PTC Therapeutics Inc. (PTCT) on Thursday reported a loss of $91.6 million in its first quarter. The South Plainfield, New Jersey-based ...

CDK9 Inhibitor Drug Pipeline Research Report 2024

13d ago, source:

KB-0742: Kronos BioKB-0742 is a selective, orally bioavailable inhibitor of CDK9, a global regulator of transcription and a critical node in the oncogenic TRN resulting from MYC overexpression. MYC is ...

Athira Pharma Appoints Javier San Martin As New Chief Medical Officer

10d ago, source:

Biopharmaceutical company Athira Pharma, Inc. (ATHA) announced Monday the appointment of Javier San Martin as Chief Medical Officer.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...